The global muscle stimulator market is projected to grow from $812 million in 2025 to $1.16 billion by 2035, at a CAGR of 3.6%. Growth is fueled by increasing use of neuromuscular electrical stimulation devices for pain management, sports rehabilitation, physiotherapy, and home healthcare. North America leads the market, while Asia Pacific is the fastest-growing region due to expanding healthcare infrastructure and rising awareness. Key segments include Transcutaneous Electrical Nerve Stimulation (TENS) and portable devices, with pain management being the largest application. Major companies are innovating with advanced portable stimulators and wireless devices to meet rising demand.
Virtuals Protocol has introduced programmable agent wallets that enforce owner-set spending limits and kill switches at the signing layer, protecting funds from AI prompt injection attacks. These wallets operate independently of the AI's decision-mak...
Nvidia is strategically investing in the AI ecosystem by subsidizing major AI infrastructure projects, similar to how a nation-state might operate. This approach is aimed at expanding its future market and creating a strong competitive moat. Early si...
Comvita reported a net profit after tax (NPAT) of $7.7 million for the fiscal year ending June 30, 2026, marking a return to profitability. The company also significantly reduced its debt, normalized inventory levels, and restored positive cash flow....
Six months after the US and Israel launched combat operations in Iran, the conflict remains a stalemate with no clear resolution. The Trump administration has shifted from military action to economic pressure, including secondary sanctions, aiming to...
The U.S. SEC declared Evernorth Holdings' Form S-4 registration effective, allowing Armada Acquisition Corp. II shareholders to vote on the proposed merger on September 30, 2026. This merger would create a Nasdaq-listed company under the ticker XRPN,...
